According to a new report, published by KBV research, The Global Nanotechnology Drug Delivery Market size is expected to reach $153.0 billion by 2030, rising at a market growth of 8.7% CAGR during the forecast period.
The Polymer-Based Nanomedicine segment is leading the Global Nanotechnology Drug Delivery Market, by Formulation in 2022; thereby, achieving a market value of $53.3 Billion by 2030. Polymer-based nanocarriers offer a wide range of tunable properties, including size, surface charge, and degradation kinetics. This versatility allows researchers to customize nanocarriers for specific therapeutic applications, addressing the diverse needs of different drugs and diseases. These factors will boost the demand in the segment.
The Infectious Diseases segment is experiencing a CAGR of 8.2% during (2023 - 2030). Nanotechnology has enabled the development of novel antimicrobial agents to combat bacterial and fungal infections. Nanoparticles, such as silver nanoparticles and nanocomposites, exhibit potent antimicrobial properties. These materials can formulate topical creams, wound dressings, and implant coatings with enhanced antibacterial efficacy. Thus, the segment will witness enhanced growth in the coming years.
Full Report: https://www.kbvresearch.com/nanotechnology-drug-delivery-market/
The North America region dominated the Global Nanotechnology Drug Delivery Market, by Region in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $66.5 Billion by 2030. The Europe region is poised to grow a CAGR of 8.5% during (2023 - 2030). Additionally, The Asia Pacific region would witness a CAGR of 9.6% during (2023 - 2030).
By Formulation
By Application
By Geography
Unique Offerings 
